BlackRock’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

BlackRock’s Portfolio IBRN Stock Details IBRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$582K	Sell	15,000 -31,000	-67%	-$1.09M	﹤0.01%	4528
2026 Q1	$1.52M	Sell	46,000 -41,000	-47%	-$1.31M	﹤0.01%	4207
2025 Q4	$2.81M	Sell	87,000 -7,000	-7%	-$211K	﹤0.01%	4019
2025 Q3	$2.52M	Hold	94,000	–	–	﹤0.01%	4020
2025 Q2	$2.06M	Sell	94,000 -9,000	-9%	-$196K	﹤0.01%	4050
2025 Q1	$2.3M	Hold	103,000	–	–	﹤0.01%	3953
2024 Q4	$2.62M	Buy	103,000 +8,000	+8%	+$212K	﹤0.01%	3963
2024 Q3	$2.38M	Hold	95,000	–	–	﹤0.01%	3946
2024 Q2	$2.24M	Hold	95,000	–	–	﹤0.01%	3934
2024 Q1	$2.43M	Hold	95,000	–	–	﹤0.01%	3940
2023 Q4	$2.49M	Sell	95,000 -50,000	-34%	-$1.09M	﹤0.01%	3950
2023 Q3	$3.04M	Hold	145,000	–	–	﹤0.01%	3861
2023 Q2	$3.52M	Hold	145,000	–	–	﹤0.01%	3847
2023 Q1	$3.46M	Sell	145,000 -5,000	-3%	-$127K	﹤0.01%	3800
2022 Q4	$3.9M	Hold	150,000	–	–	﹤0.01%	3847
2022 Q3	$3.72M	Buy	+150,000	New	+$3.64M	﹤0.01%	3889

Other funds holding IBRN

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

BlackRock's IBRN Position: Q2 2026 in Review

BlackRock reduced its iShares Neuroscience and Healthcare ETF (IBRN) stake by 67% in Q2 2026, selling an estimated $1.09M and leaving 15,000 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #4528.

BlackRock first reported a position in IBRN in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.9M in Q4 2022. 5 funds tracked by Wall St. Rank hold IBRN as of Q2 2026.

BlackRock held 15,000 shares of iShares Neuroscience and Healthcare ETF worth $582K as of Q2 2026.
BlackRock sold 31,000 iShares Neuroscience and Healthcare ETF shares in Q2 2026, an estimated $1.09M.
iShares Neuroscience and Healthcare ETF made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4528 holding.
BlackRock first reported a position in iShares Neuroscience and Healthcare ETF in Q3 2022 and has held it in 16 quarters since.
BlackRock's iShares Neuroscience and Healthcare ETF position peaked at $3.9M in Q4 2022.
5 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.